These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 711525)
1. The use of lactulose syrup for the control of hyperammonemia in Reye's syndrome: report of case. Smith VS; Mikesell D; Stoker JA J Am Osteopath Assoc; 1978 Oct; 78(2):126-9. PubMed ID: 711525 [No Abstract] [Full Text] [Related]
3. Studies on the pathophysiology of encephalopathy in Reye's syndrome; Hyperammonemia in Reye's syndrome. Shannon DC; De Long R; Bercu B; Glick T; Herrin JT; Moylan FM; Todres ID Pediatrics; 1975 Dec; 56(6):999-1004. PubMed ID: 1196768 [TBL] [Abstract][Full Text] [Related]
4. Reye's syndrome without fatty liver. Gosseye S; De Meyer R; Maldague P Helv Paediatr Acta; 1976 Apr; 30(6):509-13. PubMed ID: 1270322 [TBL] [Abstract][Full Text] [Related]
5. Arginine deficiency, hyperammonemia and Reye's syndrome in ferrets. Deshmukh DR; Thomas PE Lab Anim Sci; 1985 Jun; 35(3):242-5. PubMed ID: 2991654 [TBL] [Abstract][Full Text] [Related]
7. Biochemical correlates of illness and recovery in Reye's syndrome. Trauner D; Sweetman L; Holm J; Kulovich S; Nyhan WL Ann Neurol; 1977 Sep; 2(3):238-41. PubMed ID: 617569 [TBL] [Abstract][Full Text] [Related]
8. [Hyperlysinemia and hyperammonemia]. Rabier D; Parvy P; Bardet J; Kamoun P Ann Biol Clin (Paris); 1991; 49(1):45-8. PubMed ID: 1904697 [TBL] [Abstract][Full Text] [Related]
9. Encephalopathy of Reye's syndrome: a review of pathogenetic hypotheses. DeLong GR; Glick TH Pediatrics; 1982 Jan; 69(1):53-63. PubMed ID: 7033913 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Reye's syndrome: A working hypothesis. Thaler MM Pediatrics; 1975 Dec; 56(6):1081-4. PubMed ID: 1196760 [No Abstract] [Full Text] [Related]
11. [Bifidum-milk and lactulose in the therapy of chronic liver diseases]. Müting D; Reikowski J; Rosskopf U Med Welt; 1980 May; 31(22):857-60. PubMed ID: 7392944 [No Abstract] [Full Text] [Related]
13. Potential hazard of therapy for Reye's syndrome with urea cycle intermediates. Glasgow AM Pediatrics; 1977 Oct; 60(4):557-8. PubMed ID: 905032 [No Abstract] [Full Text] [Related]
14. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment]. Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038 [No Abstract] [Full Text] [Related]
15. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)]. Leonhardt H; Sanhueza P Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058 [No Abstract] [Full Text] [Related]
16. Prolonged continuous monitoring of intracranial pressure in severe Reye's syndrome. Shaywitz BA; Leventhal JM; Kramer MS; Venes JL Pediatrics; 1977 Apr; 59(4):595-605. PubMed ID: 850599 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose. Pirotte J; Guffens JM; Devos J Digestion; 1974; 10(6):435-44. PubMed ID: 4448315 [No Abstract] [Full Text] [Related]